American Society of Clinical Oncology

SHERPA: White

People

  1. Dickson
    Dickson
  2. D'Angelo
    D'Angelo
  3. Antonescu
    Antonescu
  4. Tap
    Tap
  5. Abramson
    Abramson
  6. Bluth
    Bluth
  7. Gordon
    Gordon
  8. Keohan
    Keohan
  9. Montefusco
    Montefusco
  10. Panageas
    Panageas

Groups

  1. Department of Medicine (6)
  2. GSK Faculty (6)
  3. Sarcoma Service (6)
  4. Solid Tumor Oncology Division (6)
  5. Biostatistics Service (4)
  6. Epidemiology and Biostatistics (4)
  7. Hematologic Malignancies, Division of (4)
  8. Surgery (4)
  9. Body Imaging Service (3)
  10. Melanoma and Immunotherapeutics Service (3)
Search Within
  1. "2012"
  2. "Sarcoma Service"
  3. "GSK Faculty"
Formats
  1. Meeting Abstract (6)
Groups
  1. Department of Medicine (6)
  2. GSK Faculty (6)
  3. Sarcoma Service (6)
  4. Solid Tumor Oncology Division (6)
  5. Biostatistics Service (4)
  6. Epidemiology and Biostatistics (4)

More Groups

People
  1. Gary Schwartz (6)
  2. Mark Dickson (5)
  3. Richard Carvajal (4)
  4. Sandra D'Angelo (4)
  5. Cristina Antonescu (3)
  6. Jedd Wolchok (3)

More People

Years
  1. 2012 (6)
Publications
  1. Journal of Clinical Oncology (6)

Results (6)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase II multicenter study of the IGF-1 receptor antibody cixutumumab (A12) and the mTOR inhibitor temsirolimus (TEM) in patients (pts) with refractory IGF-1R positive (+) and negative (-) bone and soft tissue sarcomas (STS)
    Meeting Abstract

    Schwartz, G. K.; Tap, W. D.; Qin, L. X.; Livingston, M. B.; Undevia, S. D.; Chmielowski, B.; Agulnik, M.; Schuetze, S.; Reed, D. R.; Okuno, S. H.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Evaluation of the absolute lymphocyte count as a biomarker for melanoma patients treated with the commercially available dose of ipilimumab (3mg/kg)
    Meeting Abstract

    Postow, M. A.; Yuan, J.; Panageas, K.; Bogatch, K.; Callahan, M.; Cheng, M.; Schroeder, S. E. A.; Kendle, R. F.; Harding, J. J.; Dickson, M. A.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Phase II trial of the CDK4 inhibitor PD0332991 in CDK4-amplified liposarcoma
    Meeting Abstract

    Dickson, M. A.; Keohan, M. L.; Tap, W. D.; Antonescu, C.; Landa, J.; Qin, L. X.; Dohrenwend, E. G.; Rathbone, D.; Ustoyev, Y.; Condy, M. M.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Activity of sorafenib in radiation-associated breast angiosarcomas harboring MYC and FLT4 amplifications
    Meeting Abstract

    D'Angelo, S. P.; Antonescu, C. R.; Keohan, M. L.; Carvajal, R. D.; Dickson, M. A.; Gounder, M. M.; Moraco, N. H.; Singer, S.; Schwartz, G. K.; Tap, W. D.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Pharmacodynamic activity of selumetinib to predict radiographic response in advanced uveal melanoma
    Meeting Abstract

    Carvajal, R. D.; Ambrosini, G.; Wolchok, J. D.; Chapman, P. B.; Dickson, M. A.; D'Angelo, S. P.; Bluth, M. J.; Paucar, D.; Fusco, A.; Bohr, D.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Ipilimumab in the treatment of uveal melanoma: The Memorial Sloan-Kettering Cancer Center experience
    Meeting Abstract

    Khan, S. A.; Callahan, M.; Postow, M. A.; Chapman, P. B.; Schwartz, G. K.; Dickson, M. A.; D'Angelo, S. P.; Luke, J. J.; Bluth, M. J.; Roman, R. A.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save